nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—amyotrophic lateral sclerosis	0.609	1	CbGaD
Tetrahydrobiopterin—TPH1—nerve—amyotrophic lateral sclerosis	0.0189	0.101	CbGeAlD
Tetrahydrobiopterin—TH—cranial nerve—amyotrophic lateral sclerosis	0.0175	0.0939	CbGeAlD
Tetrahydrobiopterin—TH—pons—amyotrophic lateral sclerosis	0.0173	0.0928	CbGeAlD
Tetrahydrobiopterin—TPH1—hindbrain—amyotrophic lateral sclerosis	0.0141	0.0758	CbGeAlD
Tetrahydrobiopterin—NOS3—hindlimb—amyotrophic lateral sclerosis	0.0133	0.0712	CbGeAlD
Tetrahydrobiopterin—TPH1—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0133	0.083	CbGpPWpGaD
Tetrahydrobiopterin—TH—peripheral nervous system—amyotrophic lateral sclerosis	0.0115	0.0618	CbGeAlD
Tetrahydrobiopterin—NOS3—appendage—amyotrophic lateral sclerosis	0.0114	0.0611	CbGeAlD
Tetrahydrobiopterin—PAH—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00969	0.0607	CbGpPWpGaD
Tetrahydrobiopterin—TH—nerve—amyotrophic lateral sclerosis	0.00898	0.0481	CbGeAlD
Tetrahydrobiopterin—TPH1—brainstem—amyotrophic lateral sclerosis	0.0081	0.0434	CbGeAlD
Tetrahydrobiopterin—TH—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00761	0.0476	CbGpPWpGaD
Tetrahydrobiopterin—TH—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.00741	0.0464	CbGpPWpGaD
Tetrahydrobiopterin—TH—hindbrain—amyotrophic lateral sclerosis	0.00672	0.0361	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00528	0.0331	CbGpPWpGaD
Tetrahydrobiopterin—TH—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.0047	0.0294	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.00436	0.0273	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—nervous system—amyotrophic lateral sclerosis	0.00424	0.0228	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00421	0.0226	CbGeAlD
Tetrahydrobiopterin—TH—embryo—amyotrophic lateral sclerosis	0.00421	0.0226	CbGeAlD
Tetrahydrobiopterin—TPH1—central nervous system—amyotrophic lateral sclerosis	0.00409	0.0219	CbGeAlD
Tetrahydrobiopterin—TH—brainstem—amyotrophic lateral sclerosis	0.00385	0.0207	CbGeAlD
Tetrahydrobiopterin—TH—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.0037	0.0232	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—appendage—amyotrophic lateral sclerosis	0.00361	0.0194	CbGeAlD
Tetrahydrobiopterin—PAH—nervous system—amyotrophic lateral sclerosis	0.00333	0.0179	CbGeAlD
Tetrahydrobiopterin—TPH1—brain—amyotrophic lateral sclerosis	0.00324	0.0174	CbGeAlD
Tetrahydrobiopterin—PAH—central nervous system—amyotrophic lateral sclerosis	0.00321	0.0172	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00316	0.0198	CbGpPWpGaD
Tetrahydrobiopterin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0698	CcSEcCtD
Tetrahydrobiopterin—TPH1—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00305	0.0191	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00303	0.019	CbGpPWpGaD
Tetrahydrobiopterin—TH—medulla oblongata—amyotrophic lateral sclerosis	0.00269	0.0144	CbGeAlD
Tetrahydrobiopterin—PAH—brain—amyotrophic lateral sclerosis	0.00254	0.0136	CbGeAlD
Tetrahydrobiopterin—TH—spinal cord—amyotrophic lateral sclerosis	0.0024	0.0128	CbGeAlD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00231	0.0145	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00223	0.014	CbGpPWpGaD
Tetrahydrobiopterin—TH—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00222	0.0139	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00222	0.0498	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00204	0.0127	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00204	0.0127	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00204	0.0127	CbGpPWpGaD
Tetrahydrobiopterin—TH—nervous system—amyotrophic lateral sclerosis	0.00202	0.0108	CbGeAlD
Tetrahydrobiopterin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.044	CcSEcCtD
Tetrahydrobiopterin—TH—central nervous system—amyotrophic lateral sclerosis	0.00194	0.0104	CbGeAlD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.00192	0.012	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.00192	0.012	CbGpPWpGaD
Tetrahydrobiopterin—TH—cerebellum—amyotrophic lateral sclerosis	0.0019	0.0102	CbGeAlD
Tetrahydrobiopterin—NOS3—nervous system—amyotrophic lateral sclerosis	0.00182	0.00974	CbGeAlD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00181	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0402	CcSEcCtD
Tetrahydrobiopterin—TH—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00175	0.011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—central nervous system—amyotrophic lateral sclerosis	0.00175	0.00938	CbGeAlD
Tetrahydrobiopterin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0383	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0383	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0378	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0376	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0373	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—ATXN2—amyotrophic lateral sclerosis	0.00161	0.0101	CbGpPWpGaD
Tetrahydrobiopterin—TH—brain—amyotrophic lateral sclerosis	0.00154	0.00828	CbGeAlD
Tetrahydrobiopterin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0342	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0339	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00149	0.00932	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.00932	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00149	0.00932	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.0014	0.00878	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—brain—amyotrophic lateral sclerosis	0.00139	0.00745	CbGeAlD
Tetrahydrobiopterin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00138	0.031	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00133	0.03	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.00132	0.00824	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.00129	0.00806	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00127	0.00797	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0275	CcSEcCtD
Tetrahydrobiopterin—PTGS2—embryo—amyotrophic lateral sclerosis	0.0012	0.00643	CbGeAlD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00117	0.00732	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00117	0.00732	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00117	0.00732	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0261	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00116	0.026	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0255	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0253	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0245	CcSEcCtD
Tetrahydrobiopterin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0243	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.024	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0238	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00105	0.00659	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000992	0.0223	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.00099	0.00619	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000959	0.0215	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00094	0.0211	CcSEcCtD
Tetrahydrobiopterin—TH—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.000935	0.00585	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—BDNF—amyotrophic lateral sclerosis	0.000925	0.00579	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—RAB5A—amyotrophic lateral sclerosis	0.000925	0.00579	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000891	0.02	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.000888	0.00556	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—MMP9—amyotrophic lateral sclerosis	0.000885	0.00554	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000861	0.0193	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000861	0.0193	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000806	0.00504	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000803	0.018	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000797	0.00499	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—VEGFA—amyotrophic lateral sclerosis	0.000795	0.00497	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.000793	0.00496	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000776	0.00485	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000776	0.00485	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00077	0.00482	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000766	0.00411	CbGeAlD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.000759	0.00475	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000745	0.0167	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00072	0.0162	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000709	0.00444	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000706	0.00442	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000697	0.00436	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000693	0.0156	CcSEcCtD
Tetrahydrobiopterin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000687	0.0154	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000686	0.0154	CcSEcCtD
Tetrahydrobiopterin—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000683	0.00366	CbGeAlD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—VEGFA—amyotrophic lateral sclerosis	0.000683	0.00427	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000682	0.0153	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—TPK1—amyotrophic lateral sclerosis	0.000677	0.00424	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000659	0.00413	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.000647	0.00405	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000647	0.0145	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000638	0.00399	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000629	0.00394	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—amyotrophic lateral sclerosis	0.000626	0.00392	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00062	0.00388	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000612	0.00383	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000605	0.00379	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IGF1—amyotrophic lateral sclerosis	0.000601	0.00376	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000577	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.000577	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000576	0.00309	CbGeAlD
Tetrahydrobiopterin—PAH—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000567	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000567	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000561	0.00351	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000554	0.00297	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000542	0.00339	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000542	0.00291	CbGeAlD
Tetrahydrobiopterin—PAH—Disease—VTA1—amyotrophic lateral sclerosis	0.000541	0.00339	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000541	0.00339	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000526	0.00329	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.000525	0.00329	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000519	0.00325	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000514	0.00322	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.000507	0.00317	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000482	0.00302	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000453	0.00284	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.00045	0.00281	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000447	0.00279	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000445	0.00279	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000445	0.00279	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—brain—amyotrophic lateral sclerosis	0.00044	0.00236	CbGeAlD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000437	0.00274	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000425	0.00266	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000419	0.00262	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.000417	0.00261	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000414	0.00259	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00041	0.00257	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—DAO—amyotrophic lateral sclerosis	0.00041	0.00257	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000407	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000407	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000407	0.00255	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.0004	0.0025	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.000394	0.00247	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—VEGFA—amyotrophic lateral sclerosis	0.000392	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000392	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000392	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000385	0.00241	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000379	0.00237	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000372	0.00233	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PLB1—amyotrophic lateral sclerosis	0.000371	0.00232	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TPK1—amyotrophic lateral sclerosis	0.000369	0.00231	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000368	0.0023	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00036	0.00225	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000357	0.00223	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000356	0.00223	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—amyotrophic lateral sclerosis	0.000345	0.00216	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—VCP—amyotrophic lateral sclerosis	0.000331	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000327	0.00204	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000322	0.00202	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—DAO—amyotrophic lateral sclerosis	0.000322	0.00202	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.00032	0.002	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000311	0.00194	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000309	0.00193	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000309	0.00193	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000302	0.00189	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—VTA1—amyotrophic lateral sclerosis	0.000295	0.00184	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000289	0.00181	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSR—amyotrophic lateral sclerosis	0.000287	0.00179	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000284	0.00177	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000282	0.00177	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000275	0.00172	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000263	0.00164	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000259	0.00162	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000256	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000247	0.00154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000245	0.00153	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000244	0.00153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000241	0.00151	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.00024	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000238	0.00149	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CST3—amyotrophic lateral sclerosis	0.000237	0.00148	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000235	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000227	0.00142	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000227	0.00142	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSR—amyotrophic lateral sclerosis	0.000225	0.00141	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000224	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000223	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000223	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000214	0.00134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000213	0.00133	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PLB1—amyotrophic lateral sclerosis	0.000202	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000193	0.00121	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000185	0.00116	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000182	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—VCP—amyotrophic lateral sclerosis	0.00018	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000174	0.00109	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000173	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000173	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CASP9—amyotrophic lateral sclerosis	0.000173	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000169	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000159	0.000995	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000158	0.00099	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.000977	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000156	0.000977	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000155	0.000972	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000151	0.000943	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB4—amyotrophic lateral sclerosis	0.000148	0.000924	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000146	0.000913	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000141	0.000885	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.000871	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000133	0.000832	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000131	0.000819	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CST3—amyotrophic lateral sclerosis	0.000129	0.000809	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000128	0.000802	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000127	0.000792	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000126	0.00079	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000126	0.00079	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000126	0.000789	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000122	0.000764	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	0.000121	0.000754	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000118	0.000737	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000116	0.000728	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000115	0.000723	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—APOE—amyotrophic lateral sclerosis	0.000114	0.000715	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000108	0.000678	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000107	0.000672	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000107	0.000671	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000107	0.00067	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000106	0.000664	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000101	0.000633	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000101	0.000632	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.94e-05	0.000622	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—APOE—amyotrophic lateral sclerosis	9.57e-05	0.000599	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.47e-05	0.000592	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CASP9—amyotrophic lateral sclerosis	9.39e-05	0.000588	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.13e-05	0.000572	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	9.13e-05	0.000572	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	9.13e-05	0.000571	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.97e-05	0.000561	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	8.26e-05	0.000517	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB4—amyotrophic lateral sclerosis	8.04e-05	0.000503	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—amyotrophic lateral sclerosis	7.83e-05	0.00049	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—APOE—amyotrophic lateral sclerosis	7.52e-05	0.00047	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.37e-05	0.000461	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	7.36e-05	0.000461	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.29e-05	0.000456	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.94e-05	0.000434	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.92e-05	0.000433	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.91e-05	0.000432	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.89e-05	0.000431	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	6.87e-05	0.00043	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.58e-05	0.000412	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.56e-05	0.00041	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	6.38e-05	0.0004	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.33e-05	0.000396	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOE—amyotrophic lateral sclerosis	6.22e-05	0.000389	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.18e-05	0.000387	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.81e-05	0.000364	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.63e-05	0.000352	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.29e-05	0.000331	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	5.28e-05	0.000331	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.24e-05	0.000328	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—amyotrophic lateral sclerosis	5.24e-05	0.000328	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOE—amyotrophic lateral sclerosis	5.21e-05	0.000326	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.15e-05	0.000322	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.78e-05	0.000299	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.68e-05	0.000293	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.67e-05	0.000292	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.36e-05	0.000273	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—amyotrophic lateral sclerosis	4.26e-05	0.000267	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	3.84e-05	0.00024	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.6e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.57e-05	0.000223	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	3.29e-05	0.000206	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.82e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.77e-05	0.000173	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.62e-05	0.000164	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.59e-05	0.000162	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	2.54e-05	0.000159	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.35e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.13e-05	0.000133	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.78e-05	0.000111	CbGpPWpGaD
